Atypical femur fracture during bisphosphonate drug holiday: a case series.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 25832177.
- Also identified by DOI 10.1007/s00198-015-3063-8.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent studies have noted an increased risk of low energy subtrochanteric and femoral shaft fractures termed "atypical femur fractures" (AFFs) associated with long-term bisphosphonate use. As such, many clinicians have begun recommending a "drug holiday" to reduce the risks associated with long-term bisphosphonate use. We present two cases of AFFs occurring during a 4-year or greater drug holiday following long-term bisphosphonate use. These findings highlight the need to reevaluate optimal bisphosphonate therapy duration, dosage, as well as initiation and duration of a drug holiday with continued monitoring in the prevention of AFFs.
Medical subject headings
- Bone Density Conservation Agents
- Diphosphonates
- Femoral Fractures
- Osteoporosis, Postmenopausal
- Osteoporotic Fractures